Table 3 Surgery and pathology
HIV+/HCV+ | HIV−/HCV+ | p-value | |
|---|---|---|---|
Diagnosis-to-treatment interval (months), mean ± SD | 1.2 ± 0.55 | 2.39 ± 1.09 | 0.039 |
Type of procedure, n (%) | |||
Resection | 5 (100) | 10 (90.9) | 0.99 |
Resection + ablation | 0 | 1 (9.09) | |
Surgical procedure, n (%) | |||
Open | 2 (40) | 8 (72.72) | 0.299 |
Laparoscopy | 3 (60) | 3 (27.27 | |
Type of resection, n (%) | |||
Wedge resection | 2 (40) | 9 (81.81) | 0.244 |
Segmentectomy | 3 (60) | 2 (18.18) | |
Pringle maneuver, n (%) | 1 (20) | 3 (27.27) | 0.99 |
Operative time (min), mean ± SD | 244 ± 89 | 306 ± 50 | 0.232 |
Intraoperative transfusions, n (%) | |||
Red blood cells | 1 (20) | 4 (36.36) | 0.99 |
Histological evaluation | |||
Number of nodules, n | 5 | 14a | |
Mean (range) | 1 (1; 1) | 1.27 (1; 2) | 0.242 |
Largest nodule diameter (mm) | 27 ± 14.83 | 30.7 ± 12.46 | 0.53 |
mean ± SD | |||
Edmondson-Steiner grading, n (%) | |||
1–2 | 4 (80) | 7 (63.63) | 0.99 |
3–4 | 1 (20) | 4 (36.36) | |
Microvascular invasion, n (%) | 2 (40) | 3 (27.27) | 0.99 |
Satellitosis, n (%) | 1 (20) | 1 (9.09) | 0.99 |
Residual tumor, n (%) | |||
R0 | 5 (100) | 10 (90.91) | 0.99 |
R1 | 0 | 1 (9.09) | |
Surgical margin (mm), mean ± SD | 6.25 ± 4.57 | 4 ± 3.57 | 0.473 |